Last reviewed · How we verify
Erdheim-Chester Disease
Approved treatments
- Zelboraf · Hoffmann La Roche
Zelboraf blocks the activity of the B-raf protein, which is involved in cell growth and division. - Zelboraf · Hoffmann-La Roche
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Erdheim-Chester Disease patent landscape — cliff calendar, originator estates, attackable patents
- Erdheim-Chester Disease treatment landscape brief
- Erdheim-Chester Disease treatment updates RSS
Frequently asked questions about Erdheim-Chester Disease
What drugs treat Erdheim-Chester Disease?
Tracked treatments include Zelboraf.
What is the treatment for Erdheim-Chester Disease?
Standard treatment for Erdheim-Chester Disease includes Zelboraf. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Erdheim-Chester Disease patent cliff · Erdheim-Chester Disease CI report
- Treatment: Zelboraf · Hoffmann La Roche
- Treatment: Zelboraf · Hoffmann-La Roche
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing